The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia and partners.

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer ...

American Family and Mutual of Omaha top our list of the best life insurance policies for kids in 2025. Many, or all, of the products featured on this page are from our advertising partners who ...

MONDAY, Feb. 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic ...

2. Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies.

MONDAY, Feb. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone ...

Objectives In this retrospective study we evaluated longevity in a group of GCA patients using specific gender and age-matched life expectancy tables. Methods Medical records of patients diagnosed ...

Also, the ability to return to home from hospital was associated with longevity, and so were return to work and quality of life measures within 1 year after cardiac arrest in a separate model ...

(Bassett, 1/29) MedPage Today: FDA Expands Enhertu Approval To HER2-Ultralow Breast Cancer ... (Monaco, 1/29) Axios: Racial Gaps In Life Expectancy Shrank Before COVID The gap in average life ...